首次全合成阿斯佩里内酯 B。修订阿斯佩里内酯 B 和 C 的绝对立体化学。

IF 2.9 3区化学 Q1 CHEMISTRY, ORGANIC

Organic & Biomolecular Chemistry Pub Date : 2024-06-19 DOI:10.1039/d4ob00583j

Sanja Djokić , Goran Benedeković , Jelena Kesić , Marko V. Rodić , Mirjana Popsavin , Velimir Popsavin , Jovana Francuz

{"title":"首次全合成阿斯佩里内酯 B。修订阿斯佩里内酯 B 和 C 的绝对立体化学。","authors":"Sanja Djokić , Goran Benedeković , Jelena Kesić , Marko V. Rodić , Mirjana Popsavin , Velimir Popsavin , Jovana Francuz","doi":"10.1039/d4ob00583j","DOIUrl":null,"url":null,"abstract":"<div>The first total synthesis and absolute configuration assignment of asperilactone B (I) have been accomplished. Additionally, a revision of the absolute stereochemistry of asperilactone C has been done. The first total synthesis of the opposite enantiomer of asperilactone B (ent-I) has also been achieved, as well as that of C-7 epimers of both asperilactones B (8) and C (9).</div>","PeriodicalId":96,"journal":{"name":"Organic & Biomolecular Chemistry","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First total synthesis of asperilactone B. Revision of absolute stereochemistry of asperilactones B and C†\",\"authors\":\"Sanja Djokić , Goran Benedeković , Jelena Kesić , Marko V. Rodić , Mirjana Popsavin , Velimir Popsavin , Jovana Francuz\",\"doi\":\"10.1039/d4ob00583j\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>The first total synthesis and absolute configuration assignment of asperilactone B (I) have been accomplished. Additionally, a revision of the absolute stereochemistry of asperilactone C has been done. The first total synthesis of the opposite enantiomer of asperilactone B (ent-I) has also been achieved, as well as that of C-7 epimers of both asperilactones B (8) and C (9).</div>\",\"PeriodicalId\":96,\"journal\":{\"name\":\"Organic & Biomolecular Chemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Organic & Biomolecular Chemistry\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/org/science/article/pii/S1477052024004932\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, ORGANIC\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic & Biomolecular Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/org/science/article/pii/S1477052024004932","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}

引用次数: 0

摘要

首次完成了阿斯佩里内酯 B (I) 的全合成和绝对构型分配。此外，还对阿斯佩里内酯 C 的绝对立体化学进行了修订。此外，还首次合成了阿斯佩里内酯 B 的对映体（ent-I），以及阿斯佩里内酯 B (8) 和 C (9) 的 C-7 外比体。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

First total synthesis of asperilactone B. Revision of absolute stereochemistry of asperilactones B and C†

查看原文本刊更多论文

First total synthesis of asperilactone B. Revision of absolute stereochemistry of asperilactones B and C†

The first total synthesis and absolute configuration assignment of asperilactone B (I) have been accomplished. Additionally, a revision of the absolute stereochemistry of asperilactone C has been done. The first total synthesis of the opposite enantiomer of asperilactone B (ent-I) has also been achieved, as well as that of C-7 epimers of both asperilactones B (8) and C (9).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Organic & Biomolecular Chemistry 化学-有机化学

CiteScore

5.50

自引率

9.40%

发文量

1056

审稿时长

1.3 months

期刊介绍： The international home of synthetic, physical and biomolecular organic chemistry.